SparkRx is a five-week program designed to reduce symptoms of adolescent depression. Developed with leading experts in adolescent psychology and co-designed with teens, the SparkRx program moves users through a combination of psychoeducation and interactive exercises, where they can gain insights about how depression impacts their mood, emotions, and behavior. SparkRx is designed to be an adjunct treatment for symptoms of adolescent depression.

Additional Information:
SparkRx is a digital therapeutic intended to provide a neurobehavioral intervention (Cognitive Behavioral Therapy - Behavioral Activation) in patients 13 to 22 years of age as adjunct treatment for symptoms of depression.

SparkRx has not been cleared or approved by the U.S. Food and Drug Administration. During the COVID-19 public health emergency, SparkRx is being made available without a prescription under FDA’s ”Enforcement Policy for Digital Health Devices For Treating Psychiatric Disorders During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency.”

SparkRx is not meant to be used as treatment without supervision of a health care provider.
SparkRx is not meant to be a substitution for any treatment or medication.
SparkRx does not address concerns of active suicidal ideation with intent.
SparkRx is not intended for the prevention of suicide attempts or self-harm behaviors.
See instructions for use at SparkRx.com for complete safety & use information